Loading...
XSHE
300501
Market cap477mUSD
Oct 09, Last price  
11.50CNY
1D
0.17%
1Q
-5.66%
Jan 2017
-68.65%
IPO
-6.53%
Name

Shanghai Haishun New Pharmaceutical Packaging Co Ltd

Chart & performance

D1W1MN
XSHE:300501 chart
P/E
—
P/S
2.91
EPS
—
Div yield, %
3.55%
Shrs. gr., 5y
1.82%
Rev. gr., 5y
5.14%
Revenues
1.10b
-3.65%
149,003,104210,237,307277,366,830289,849,721293,978,430301,275,887375,617,176507,195,935621,030,369713,784,960856,857,795856,857,7951,012,601,2351,012,601,2341,020,872,0061,142,549,8211,100,812,539
Net income
-23m
L
19,791,06734,058,14244,466,12954,224,08858,767,41764,603,52765,811,23566,165,09966,976,224102,903,830104,645,765104,645,769102,461,491102,461,49785,441,74474,589,984-23,266,931
CFO
163m
+0.74%
8,503,94226,495,96528,403,10462,805,42553,274,73033,462,32055,089,70327,489,66795,878,08277,485,971139,639,384136,957,656100,596,590161,307,846162,508,877
Dividend
Apr 28, 20260.876 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

HySum Flexibles Global, Inc. operates as a manufacturer, distributor, and international exporter of packaging solutions, with a primary focus on the pharmaceutical sector. The company's reach extends throughout China and into global markets. Its extensive catalog for pharmaceutical packaging features products such as cold-form and tropical foils, PVC/Aclar sheets, PTP lidding, and a variety of "hipack" offerings like child-resistant packaging, AL/PE strip packs, complex laminated flexible films, and AL/PE suppository laminates. Additional items include lamination foil and pouches, composite films, PVC, PVDC/PVC pharmaceutical packaging, PE series bags, and bottles crafted from PP, PE, and COP materials. Beyond pharmaceuticals, HySum also caters to the food industry, supplying three-layer co-extruded PE films, high-barrier films produced via top-blown and bottom-blown multi-layer co-extrusion, and multi-layer co-extruded sheets. The company further supports the new energy material sector with specialized aluminum plastic films. Its precision injection packaging division delivers products such as precision injection molded packaging, desiccant combinations, exact dosing devices, diagnostic reagent packages, and both plastic and high-barrier vaccine vials. Established in 2005, the company was formerly known as Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. It officially rebranded to HySum Flexibles Global, Inc. in January 2024. The corporate headquarters are situated in Shanghai, China.

Key people

Hailong Ni
Finance Director, Director · since 2025
Ping Chen
Deputy General Manager · since 2012
Jian Fu
Deputy General Manager · since 2025
Qin Huang
Chairman of the Board, General Manager · since 2025
Gaofeng Yang
Secretary of the Board · since 2020
Xin Lin
Director · since 2022
Ruihua Shi
Staff Elected Director · since 2025
Xun Guo
Independent Director · since 2024
Shihong Ma
Independent Director · since 2020
Linlin Wang
Independent Director · since 2022
IPO date
Feb 04, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT